行情

NLTX

NLTX

Neoleukin Therapeutics
NASDAQ

实时行情|Nasdaq Last Sale

11.38
+0.32
+2.89%
已收盘, 16:00 01/28 EST
开盘
11.20
昨收
11.06
最高
11.88
最低
11.20
成交量
28.14万
成交额
--
52周最高
13.43
52周最低
2.180
市值
5.53亿
市盈率(TTM)
-4.4458
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NLTX 新闻

  • 韩国将新冠肺炎纳入甲级传染病管理
  • 新浪财经.4小时前
  • 澳大利亚拟将海外领地圣诞岛设为疫情隔离点
  • 新浪财经.4小时前
  • Facebook内容监督委员会方案:有权否决扎克伯格意见
  • 新浪科技.5小时前
  • 摩根大通拟在消费者部门裁员数百人
  • 新浪财经.5小时前

更多

所属板块

生物技术和医学研究
+0.97%
制药与医学研究
+0.58%

热门股票

名称
价格
涨跌幅

NLTX 简况

Neoleukin Therapeutics, Inc., formerly Aquinox Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on the development and commercialization of computationally-designed protein therapeutics to address unmet medical needs in immuno-oncology, inflammation, and autoimmunity. Its computational platform allows it to design new de novo proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its lead program, NL-201, is a computationally-designed de novo protein therapeutic. NL-201 is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. NL-201 is designed for use as a single-agent or in combination with complementary therapeutic modalities.
展开

Webull提供Neoleukin Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。